Truvestments Capital’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-217
Closed -$6.53K 1039
2025
Q3
$6.53K Sell
217
-178
-45% -$3.85K ﹤0.01% 774
2025
Q2
$5.11K Hold
395
﹤0.01% 734
2025
Q1
$2.88K Sell
395
-2,185
-85% -$24.2K ﹤0.01% 821
2024
Q4
$42.9K Sell
2,580
-207
-7% -$2.76K 0.01% 392
2024
Q3
$35.8K Buy
+2,787
New +$40.3K 0.01% 410
2024
Q2
Sell
-3,756
Closed -$46.6K 230
2024
Q1
$46.6K Sell
3,756
-6,725
-64% -$112K 0.02% 357
2023
Q4
$278K Buy
10,481
+2,470
+31% +$72K 0.13% 176
2023
Q3
$366K Buy
8,011
+926
+13% +$42.9K 0.19% 100
2023
Q2
$292K Buy
7,085
+1,170
+20% +$38.4K 0.15% 128
2023
Q1
$183K Buy
5,915
+1,527
+35% +$49.2K 0.1% 178
2022
Q4
$88.2K Buy
4,388
+3,158
+257% +$67.6K 0.05% 260
2022
Q3
$17K Buy
1,230
+103
+9% +$1.39K 0.01% 352
2022
Q2
$8K Buy
+1,127
New +$9.36K ﹤0.01% 434

Other funds holding AEHR

Truvestments Capital's AEHR Position: Q4 2025 in Review

Truvestments Capital sold out of Aehr Test Systems (AEHR) in Q4 2025, closing a stake of 217 shares — an estimated $6.53K sold.

Truvestments Capital first reported a position in AEHR in Q2 2022 and held it in 13 quarters. The position peaked at $366K in Q3 2023. 150 funds tracked by Wall St. Rank hold AEHR as of Q4 2025.

  • Truvestments Capital reported no remaining Aehr Test Systems position as of Q4 2025 after selling out during the quarter.
  • Truvestments Capital sold 217 Aehr Test Systems shares in Q4 2025, an estimated $6.53K.
  • Truvestments Capital first reported a position in Aehr Test Systems in Q2 2022 and held it in 13 quarters.
  • Truvestments Capital's Aehr Test Systems position peaked at $366K in Q3 2023.
  • 150 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2025.

Based on Truvestments Capital's 13F filing for Q4 2025, filed 13 Feb 2026.